Celcuity Inc (CELC) Stock Price, Quote, News & History

CELCNASDAQ
$93.65
0.410.44%
At close: Aug 18, 5:00 PM EST
$93.65
0.410.44%
Pre-Market: 4:01 AM EST
Earnings: Q2 2026 Earnings were released on Thu Aug 13th, after the market close
Conference Call: The most recent conference call started at 4:30 PM, 7 days ago
Click to view the webcast

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-191.71M
Investing Cash Flow (TTM)
-450.27M
Financing Cash Flow (TTM)
777.67M
Free Cash Flow (TTM)
-192.28M
Capital Expenditure (TTM)
-571.00K
Net Change in Cash (TTM)
135.70M

Analyst Trends and Forecast

6
May
3
Jun
1
Jul
4
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$4.58B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-4.59%
Earnings Yield % (FWD)
-5.42%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$0.26

Company Debt

Total Debt
$753.24M
LT Debt
$753.24M
LT Debt Issuance (TTM)
$780.17M
LT Debt Repayment (TTM)
-
Total Cash
$182.05M
Debt to Equity
-
Issuance of Debt (TTM)
$643.15M
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$93.65
Volume / Avg.
0 / 1.50M
Day Range
- - -
52 Wk Range
44.42 - 151.02
Market Cap
$4.58B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
53
Short Interest
31.46%
Days to Cover
6.75

About

Sector
Health Care
Industry
Biotechnology
Celcuity Inc is a clinical-stage biotechnology company developing targeted therapies for multiple solid tumors. Its candidate, gedatolisib, is a kinase inhibitor of the PI3K/AKT/mTOR (PAM) pathway, binding all class I PI3K isoforms and mTORC1/2, offe...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Celcuity (CELC) stock?

A

You can purchase shares of Celcuity (NASDAQ:CELC) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for Celcuity (CELC) stock?

A

Celcuity has a consensus price target of $125.62.

Q

What is the current price for Celcuity (CELC)?

A

The stock price for Celcuity (NASDAQ: CELC) is $93.65 last updated August 19, 2026 at 4:38 PM EDT.

Q

Does Celcuity (CELC) pay a dividend?

A

There are no upcoming dividends for Celcuity.

Q

When is Celcuity (NASDAQ:CELC) reporting earnings?

A

Celcuity does not have any upcoming earnings scheduled.

Q

Is Celcuity (CELC) going to split?

A

There is no upcoming split for Celcuity.

Q

What sector and industry does Celcuity (CELC) operate in?

A

Celcuity is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.